TY - JOUR
T1 - Long-term outcomes of dialysis patients after coronary revascularization
T2 - A population-based cohort study in Taiwan
AU - Chou, Chu lin
AU - Hsieh, Tsung cheng
AU - Wang, Chih hsien
AU - Hung, Tsung hsing
AU - Lai, Yu hsien
AU - Chen, Yi ya
AU - Lin, Yu li
AU - Kuo, Chiu huang
AU - Wu, Ya ju
AU - Fang, Te chao
N1 - Funding Information:
We thank the Bureau of Health Promotion, Department of Health, and National Health Research Institutes for providing us access to the National Health Insurance research database. This study is based in part on data from the NHIRD, which are provided by the Bureau of NHI and Department of Health and managed by the National Health Research Institutes (registry no. 99041 or NHIRD-CF-001). The interpretations and conclusions contained herein do not represent those of the Bureau of NHI, Department of Health, or National Health Research Institutes. This study was supported by a grant ( TCRD 100–56 ) from Tzu Chi General Hospital, Hualien, Taiwan , and will be presented at the Kidney Week of the American Society of Nephrology (Atlanta, GA, USA) held from November 5 to November 10, 2013.
PY - 2014/2
Y1 - 2014/2
N2 - Background and Aims: The outcomes of Chinese patients undergoing dialysis after coronary revascularization are unknown. We examined the outcomes of Taiwanese dialysis patients after coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), or coronary stenting. Methods: Using data from the National Health Research Institute database, we determined the outcomes of 1,287 dialysis patients who underwent initial coronary revascularization between 1997 and2008. Results: The 7-year overall survival rates were 69 ± 4%, 68 ± 3%, and 57 ± 2% for the CABG, stent, and PTCA patients (p= 0.001), respectively. After demographic and comorbidity adjustment, hazard ratios (HRs) for all-cause death in the CABG (vs. PTCA) and stent (vs. PTCA) patients were 0.695 (p= 0.015) and 0.721 (p= 0.009). Additionally, no significant difference in all-cause death was found between the CABG and stent patients. Moreover, the ≥65-year-old CABG group patients and the
AB - Background and Aims: The outcomes of Chinese patients undergoing dialysis after coronary revascularization are unknown. We examined the outcomes of Taiwanese dialysis patients after coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), or coronary stenting. Methods: Using data from the National Health Research Institute database, we determined the outcomes of 1,287 dialysis patients who underwent initial coronary revascularization between 1997 and2008. Results: The 7-year overall survival rates were 69 ± 4%, 68 ± 3%, and 57 ± 2% for the CABG, stent, and PTCA patients (p= 0.001), respectively. After demographic and comorbidity adjustment, hazard ratios (HRs) for all-cause death in the CABG (vs. PTCA) and stent (vs. PTCA) patients were 0.695 (p= 0.015) and 0.721 (p= 0.009). Additionally, no significant difference in all-cause death was found between the CABG and stent patients. Moreover, the ≥65-year-old CABG group patients and the
KW - Coronary artery bypass grafting
KW - Dialysis
KW - Percutaneous transluminal coronary angioplasty
KW - Stent
UR - http://www.scopus.com/inward/record.url?scp=84896808646&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896808646&partnerID=8YFLogxK
U2 - 10.1016/j.arcmed.2014.01.009
DO - 10.1016/j.arcmed.2014.01.009
M3 - Article
C2 - 24512923
AN - SCOPUS:84896808646
SN - 0188-4409
VL - 45
SP - 188
EP - 194
JO - Archives of Medical Research
JF - Archives of Medical Research
IS - 2
ER -